ACADIA Pharmaceuticals initiates phase 3 pivotal study of trofinetide in Rett Syndrome

ACADIA Pharmaceuticals initiates phase 3 pivotal study of trofinetide in Rett Syndrome. Photo: courtesy of Philippe Delavie from Pixabay.